دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Hemodynamic Assessment in Takotsubo Syndrome
Thomas Stiermaier, MD, a,b, * Jan-Christian Reil, MD,a,c, * Vasco Sequeira, P HD, d Elias Rawish, MD,a,b Matthias Mezger, MD, a Toni P?tz, MD,a Christina Paitazoglou, MD,a Tobias Schmidt, MD,a Christian Frerker, MD,a Paul Steendijk, PHD, e Gert-Hinrich Reil, MD, f Ingo Eitel, MD
doi : 10.1016/j.jacc.2023.03.398
Volume 81, Issue 20, 23 May 2023, Pages 1979-1991
Takotsubo syndrome (TTS) is a reversible form of heart failure with incompletely understood pathophysiology.
Novel Hemodynamic Insights in Takotsubo Syndrome∗
Jorge Salamanca, MD, Fernando Alfonso, MD, PHD
doi : 10.1016/j.jacc.2023.03.399
Volume 81, Issue 20, 23 May 2023, Pages 1992-1995
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease
Esra D. Gumuser, MD, a, * Art Schuermans, BS C,b,c,d, * So Mi Jemma Cho, PH D, b,c,e Zachary A. Sporn, MD,a Md Mesbah Uddin, PHD, b,c Kaavya Paruchuri, MD,b,c Tetsushi Nakao, MD, PHD, b,c,f,g Zhi Yu, MB, PHD, b,c Sara Haidermota, BS, b,c Whitney Hornsby, P HD, b,c Lachelle D. Weeks, MD, PH D, f Abhishek Niroula, PHD, b,f,h Siddhartha Jaiswal, MD, PH D, i Peter Libby, MD, g Benjamin L. Ebert, MD, P HD, f Alexander G. Bick, MD, P HD, j Pradeep Natarajan, MD, MMS C ,a,b,c Michael C. Honigberg, MD, MPP
doi : 10.1016/j.jacc.2023.03.401
Volume 81, Issue 20, 23 May 2023, Pages 1996-2009
Clonal hematopoiesis of indeterminate potential (CHIP)—the age-related clonal expansion of blood stem cells with leukemia-associated mutations—is a novel cardiovascular risk factor. Whether CHIP remains prognostic in individuals with established atherosclerotic cardiovascular disease (ASCVD) is less clear.
Clonal Hematopoiesis in Patients With Atherosclerotic Cardiovascular Disease: One Step Closer to the Clinical Scenario∗
José J. Fuster, PH D, a,b Benedetta Izzi, PHD a
doi : 10.1016/j.jacc.2023.03.420
Volume 81, Issue 20, 23 May 2023, Pages 2010-2012
Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload
Frederik H. Verbrugge, MD, PHD, MS,a,b Pieter Martens, MD, PH D, c,d Jeroen Dauw, MD,c,e Petra Nijst, MD, P HD, c Evelyne Meekers, MD,c,e Silvio Nunes Augusto, J R , MS C,d Jozine M. ter Maaten, MD, PH D, f Kevin Damman, MD, PHD, f Gerasimos Filippatos, MD, PHD, g Johan Lassus, MD, PHD, h Alexandre Mebazaa, MD, P HD, i Frank Ruschitzka, MD, PH D, j Matthias Dupont, MD, c Wilfried Mullens, MD, PHD
doi : 10.1016/j.jacc.2023.03.400
Volume 81, Issue 20, 23 May 2023, Pages 2013-2024
Natriuretic Response as a Biomarker of Decongestion in ADHF: Beyond Going With the Flow∗
Emer Joyce, MB, BCH, PH D
doi : 10.1016/j.jacc.2023.03.405
Volume 81, Issue 20, 23 May 2023, Pages 2025-2027
Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S. Adults
John W. McEvoy, MB, BC H , MHS, PHD, a,b,c Olive Tang, MD, PHD, b Dan Wang, MS, c Chiadi E. Ndumele, MD, PHD, b,c Josef Coresh, MD, P HD, c Robert H. Christenson, P HD, d Elizabeth Selvin, MPH, PH D
doi : 10.1016/j.jacc.2023.03.403
Volume 81, Issue 20, 23 May 2023, Pages 2028-2039
Myocardial injury is currently defined as a cardiac troponin above the sex-specific 99th percentile of a healthy reference population (upper reference limit [URL]).
What Is a Normal Troponin, Anyway?∗
Cian P. McCarthy, MB, BC H, BAO, a Austin Vyas, BS, b James L. Januzzi, J R, MD
doi : 10.1016/j.jacc.2023.03.404
Volume 81, Issue 20, 23 May 2023, Pages 2040-2042
Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of the Week
Smrithi Sukumar, MD,a Jason H. Wasfy, MD, MP HIL,b James L. Januzzi, MD,b Jeffrey Peppercorn, MD, MPH,c Fumiko Chino, MD,d Haider J. Warraich, MD
doi : 10.1016/j.jacc.2023.03.402
Volume 81, Issue 20, 23 May 2023, Pages 2043-2055
Optimal medical management of heart failure (HF) improves quality of life, decreases mortality, and decreases hospitalizations. Cost may contribute to suboptimal adherence to HF medications, especially angiotensin receptor-neprilysin inhibitors and sodium-glucose cotransporter-2 inhibitors.
Prognostic Value of Etiology in Patients With Recurrent Pericarditis
Abdullah Yesilyaprak, MD Ashwin K. Kumar, MD Ankit Agrawal, MD Beni Verma, MD Felix Berglund, MD Massimo Imazio, MD Tom Wang, MD Christine L. Jellis, MD Paul C. Cremer, MD, MS *Allan L. Klein, MD
doi : 10.1016/j.jacc.2023.03.406
Volume 81, Issue 20, 23 May 2023, Pages 2056-2058
Uncovering Risk Factors for In-Hospital Cardiac Arrest in ST-Segment Elevation Myocardial Infarction
Toshiki Kuno, MD, PhD Shun Kohsaka, MD, PhD
doi : 10.1016/j.jacc.2023.01.050
Volume 81, Issue 20, 23 May 2023, Page e171
Reply: Uncovering Risk Factors for In-Hospital Cardiac Arrest in ST-Segment Elevation Myocardial Infarction
Wei Gong, MD, PhD Yan Yan, MD Gilles Montalescot, MD, PhD *Shaoping Nie, MD, PhD
doi : 10.1016/j.jacc.2023.03.408
Volume 81, Issue 20, 23 May 2023, Page e173
